GlassScriptPhysician profile
Seth J Kligerman
NPI 1386790053
$56,671.85
in general payments reported to CMS, 2019-2025
8 companies · $312 in 2025
The $312 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $5,776 · 2021: $6,768 · 2022: $3,803 · 2023: $326 · 2024: $27K · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $25K · Travel and Lodging: $1,512 · Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $24,925.00 |
| Travel and Lodging | $1,512.15 |
| Food and Beverage | $805.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $52,384.63 | 2019-2024 | Ofev |
| Boehringer Ingelheim Malaysia Sdn. Bhd. | $2,745.00 | 2021 | |
| Cleerly, INC. | $684.37 | 2023-2025 | Cleerly Labs, Cleerly Ischemia |
| Ge Healthcare | $428.23 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $213.64 | 2022-2023 | Naeotom Alpha |
| Aidoc Medical LTD | $105.00 | 2021 | |
| Bracco Diagnostics INC. | $94.88 | 2020 | |
| Heartflow, INC. | $16.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Kligerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.